Clinical Trial

A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with SLE.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-23.
Trial Details
NCT Number NCT06900764
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions Systemic Lupus Erythematosus (SLE)
Enrollment 24 participants
Start Date 2025-10-10
Primary Completion 2027-11-15 (estimated)
Study Completion 2027-12-20 (estimated)
Updated on ClinicalTrials.gov 2025-07-17